Trulieve and Cronos Outpace the S&P 500 in 2026
Both cannabis companies are up about 27% this year, backed by stronger cash flow, sales growth and shareholder returns.
Makkler Newsroom · Sep 23, 11:27 PM · 2 min read
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO